Multiparametric MRI prior to radical prostatectomy identifies intraductal and cribriform growth patterns in prostate cancer

Abstract

<div lang="en" class="abs"><p class="abs_header">Abstract</p><p><em>Objectives:</em> To evaluate the diagnostic value of multiparametric prostate magnetic resonance imaging (mpMRI) prior to radical prostatectomy with curative intent for the detection of cribriform architecture (CA) and intraductal prostate cancer (IDC), which have recently been demonstrated to be adverse pathological features.</p><p><em>Patients and Methods:</em> The study included 124 men who underwent mpMRI prior to radical prostatectomy at our centre. Preoperative mpMRI, prostatectomy histology and clinical follow‐up details were reviewed retrospectively. The diagnostic value of mpMRI was evaluated on the basis of the detection rate. Secondly, the prognostic significance of CA/IDC among grade group (GG)2 cancers with regard to biochemical recurrence (BCR)‐free survival was assessed using Kaplan–Meier analysis, with the log rank test and Fisher’s exact test.</p><p><em>Results:</em> Pathological examination of radical prostatectomy specimens identified CA/IDC in 89 of 124 cases (71%) and mpMRI identified 86/95 of tumours including any CA/IDC with a sensitivity of 90.5% (95% confidence interval 82.8–95.6%). When localization of the lesions was compared, there was an association between the highest Prostate Imaging‐Reporting and Data System classification and the highest pathological grade in 106 of the 124 cases (85.5%). In patients with GG2 lesions, BCR occurred in 11 of 31 (35.5%) with CA/IDC and two of 21 (9.5%) without CA/IDC (<em>P</em> = 0.034). </p><p><em>Conclusion:</em> Multiparametric MRI has good sensitivity for detection of pathological primary prostate cancer, including most cases with CA/IDC; however, reliable prediction of GG2 tumours with CA/IDC for individual risk stratification remains challenging.</p></div>